Stock Code: Tianshui Zhongxing Bio-Technology Co.Ltd(002772) stock abbreviation: Tianshui Zhongxing Bio-Technology Co.Ltd(002772) Announcement No.: 2022021 bond Code: 128026 bond abbreviation: Zhongxing convertible bond
Tianshui Zhongxing Bio-Technology Co.Ltd(002772)
Announcement of the special report on the deposit and use of raised funds in 2021
The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete without false records, misleading statements or major omissions.
Tianshui Zhongxing Bio-Technology Co.Ltd(002772) (hereinafter referred to as “the company”) the board of directors in accordance with the relevant provisions of the China Securities Regulatory Commission, such as the guidelines for the supervision of listed companies No. 2 – regulatory requirements for the management and use of raised funds by listed companies (revised in 2022) and the Shenzhen Stock Exchange self regulatory guidelines for listed companies No. 1 – standardized operation of listed companies on the main board, The special report on the annual storage and actual use of raised funds was prepared. On March 23, 2022, the 12th meeting of the Fourth Board of directors of the company deliberated and approved the proposal on reviewing the special report on the annual storage and actual use of raised funds. The board of supervisors and independent directors of the company have issued clearly agreed audit opinions on the report, and the audit institution China audit Zhonghuan Certified Public Accountants (special general partnership) has issued an assurance report, The sponsor China International Capital Corporation Limited(601995) has issued special verification opinions, and the proposal needs to be submitted to the general meeting of shareholders for deliberation. The details are as follows:
1、 Basic information of raised funds
During the reporting period, the raised funds deposited and used by the company were raised by public issuance of convertible corporate bonds. Approved by the reply on approving Tianshui Zhongxing Bio-Technology Co.Ltd(002772) public issuance of convertible corporate bonds (zjxk [2017] No. 2002) of the China Securities Regulatory Commission, the company publicly issued 9.2 million convertible corporate bonds on December 13, 2017, with a face value of 100 yuan each, issued at par with the face value, and raised a total of 92 million yuan after deducting the issuance expenses, The net amount of funds actually raised was 902.9 million yuan. The above funds have been verified by Zhongshen Zhonghuan Certified Public Accountants (special general partnership) and issued the capital verification report (zhyz (2017) No. 080011).
As of December 31, 2021, the principal and interest of the funds raised by the public issuance of convertible corporate bonds totaled 9410492 million yuan (excluding bank handling charges). The company has put the accumulated amount of funds raised into use was 5531712 million yuan, including 199633 million yuan in this reporting period and 5334779 million yuan in previous years, The total balance of principal and interest of unused raised funds is 387878 million yuan.
2、 Deposit and management of raised funds
(I) formulation and implementation of raised funds management system
In order to standardize the management and use of raised funds and protect the legitimate rights and interests of investors, the company has formulated the measures for the management of Tianshui Zhongxing Bio-Technology Co.Ltd(002772) raised funds in accordance with the company law, the securities law, the self regulatory guidelines for listed companies on the Shenzhen Stock Exchange No. 1 – standardized operation of companies listed on the main board and the articles of association, and in combination with the actual situation of the company Strict provisions have been made on the investment direction change of raised funds, the management and supervision of raised funds and information disclosure.
(II) storage and management of special account for raised funds
1. Storage of raised funds in special account
According to the provisions of the measures for the administration of Tianshui Zhongxing Bio-Technology Co.Ltd(002772) raised funds, on December 19, 2017, the company held the 38th meeting of the second board of directors and deliberated and adopted the proposal on opening a special account for raised funds from public issuance of convertible corporate bonds and signing a supervision agreement. As of January 11, 2018, the company and its subsidiaries Anyang Tianshui Zhongxing Bio-Technology Co.Ltd(002772) Technology Co., Ltd., Jilin Tianshui Zhongxing Bio-Technology Co.Ltd(002772) Technology Co., Ltd. and Wuwei Tianshui Zhongxing Bio-Technology Co.Ltd(002772) Technology Co., Ltd. had signed the fund-raising supervision agreement with the storage bank and the sponsor China International Capital Corporation Limited(601995) as follows:
Sequence project name bank account name bank account number amount (10000 yuan) No
Annual output of 20000 tons of Agaricus bisporus Bank Of Communications Co.Ltd(601328) shares Anyang Tianshui Zhongxing Bio-Technology Co.Ltd(002772) branch
1 and 110000 ton compost Factory Chemical Co., Ltd. 72903012801801006865742290.00 production project Tianshui branch
2. Annual output of 32400 tons of Flammulina velutipes Gansu bank tianjilin Tianshui Zhongxing Bio-Technology Co.Ltd(002772) 6101240020001365024000.00 production line construction project water branch Technology Co., Ltd
Annual output of 32400 tons of Flammulina velutipes Bank Of Communications Co.Ltd(601328) guwuwei Tianshui Zhongxing Bio-Technology Co.Ltd(002772) branch
3. Industrial Technology Co., Ltd. of industrialized circular economy 7290301100180101120 Guangdong Advertising Group Co.Ltd(002400) 0.00 chain construction project Tianshui branch
Total 9029000
Note: the announcement on signing the supervision agreement on raised funds (Announcement No.: 2018004) is detailed in the information disclosure media designated by the company on January 12, 2018, such as securities times, Shanghai Securities News and cninfo（ http://www.cn.info.com.cn. ）。
2. Change of special account for deposit of raised funds
On September 22, 2020, the company held the 34th meeting of the third board of directors and the 20th meeting of the third board of supervisors, deliberated and adopted the proposal on changing the special account for raised funds. In order to strengthen the management of raised funds, Anyang Tianshui Zhongxing Bio-Technology Co.Ltd(002772) Technology Co., Ltd. and Wuwei Tianshui Zhongxing Bio-Technology Co.Ltd(002772) Technology Co., Ltd. applied to Bank of Gansu for the establishment of a new special account for raised funds. On September 28, 2020, Anyang Tianshui Zhongxing Bio-Technology Co.Ltd(002772) Technology Co., Ltd. and Wuwei Tianshui Zhongxing Bio-Technology Co.Ltd(002772) Technology Co., Ltd. signed a supervision agreement on the raised funds with the new storage bank Gansu bank and the sponsor China International Capital Corporation Limited(601995) and the original special account for the raised funds has been cancelled.
After the change of the deposit account of the raised funds, the deposit of the raised funds and the balance of each special account as of the end of the reporting period are as follows:
Unit: 10000 yuan
Preface current reporting period
Project No.: name of deposit bank account name of bank account closing balance
(including interest)
With an annual output of 20000 tons of Agaricus bisporus and 110000 tons, Bank of Gansu Anyang Tianshui Zhongxing Bio-Technology Co.Ltd(002772)
1 ton compost industrialized production project Tianshui Branch Technology Co., Ltd. 610124010 China Union Holdings Ltd(000036) 7412236.14
2 production line of Flammulina velutipes with an annual output of 32400 tons Bank of Gansu Jilin Tianshui Zhongxing Bio-Technology Co.Ltd(002772) 6101240020001365021970.49 construction project Tianshui Branch Technology Co., Ltd
Annual output of 32400 tons of Flammulina velutipes industrialized Bank of Gansu Wuwei Tianshui Zhongxing Bio-Technology Co.Ltd(002772)
3 circular economy industrial chain construction project Tianshui Branch Technology Co., Ltd. 610124010 China Union Holdings Ltd(000036) 634581.17
Total 3878780
The announcement on signing the supervision agreement on raised funds (Announcement No.: 2020103) and the announcement on the completion of cancellation of some special accounts for raised funds (Announcement No.: 2020104) are detailed in the information disclosure media designated by the company on October 10, 2020, such as securities times, securities daily and cninfo.com（ http://www.cn.info.com.cn. ）。
3. Use the raised funds to replace the self raised funds of the raised investment projects that have been invested in advance
On January 12, 2018, the company held the 40th meeting of the second board of directors and the 28th meeting of the second board of supervisors, deliberated and approved the proposal on using the raised funds to replace the self raised funds of the pre invested projects. The board of directors agreed that the company would use the raised funds of 30484613632 yuan to replace the pre invested “industrial production project with an annual output of 20000 tons of Agaricus bisporus and 110000 tons of compost” Self raised funds for “production line construction project with annual output of 32400 tons of Flammulina velutipes” and “industrial chain construction project with annual output of 32400 tons of industrialized circular economy of Flammulina velutipes”. Announcement on using raised funds to replace self raised funds of pre invested projects (Announcement No.: 2018007) the information disclosure media designated by the company include securities times, Shanghai Securities News and cninfo.com（ http://www.cn.info.com.cn. ）。
4. Some idle raised funds are managed in cash
The first extraordinary general meeting of the company in 2018, the annual general meeting of shareholders in 2018 and the first extraordinary general meeting of shareholders in 2020 all considered and approved the proposal of using some idle raised funds for cash management. Under the condition of ensuring that the investment projects of the company’s raised funds will not be affected, some idle raised funds will be managed in cash to improve the use efficiency of raised funds. For details of the announcement on using some idle raised funds for cash management (Announcement No.: 2018008 / 2019013 / 2020027), please refer to cninfo.com, the company’s designated information disclosure website（ http://www.cn.info.com.cn. ）。
3、 Actual use of raised funds this year
For the actual use of the funds raised by the company’s public issuance of convertible corporate bonds in 2021, please refer to the “comparison table of the use of funds raised by public issuance of convertible corporate bonds” (attached Table 1-1).
4、 Problems in the use and disclosure of raised funds
The company deposited and used the raised funds in accordance with the provisions and requirements of relevant laws, regulations and normative documents such as the guidelines for self discipline supervision of listed companies of Shenzhen Stock Exchange No. 1 – standardized operation of listed companies on the main board and the measures for the administration of Tianshui Zhongxing Bio-Technology Co.Ltd(002772) raised funds, and disclosed the use of raised funds in a timely, true, accurate and complete manner. There were no violations in the use and management of raised funds.
It is hereby announced
Tianshui Zhongxing Bio-Technology Co.Ltd(002772) board of directors
March 23, 2022
Comparison table of use of funds raised by public issuance of convertible corporate bonds
Year 2021
Prepared by: Tianshui Zhongxing Bio-Technology Co.Ltd(002772) amount unit: RMB 10000
The total amount of raised funds is 9029000, and the total amount of raised funds invested in this year is 196933
The total amount of raised funds with changed purposes during the reporting period was 0
Accumulated total amount of raised funds with changed purposes
